MarketCap
Facebook
X
Telegram
GeoVax Labs Income Statement 2025-2001 | GOVX
Brief overview of financial results at GeoVax Labs
The overview follows changes across a five-year period. The revenue attributed to GeoVax Labs moved from 1.8 million dollars to 2.5 million dollars between the two endpoints. The cumulative result was +36.5%, corresponding to roughly 6.4% per year. Sales increased steadily, although without strong acceleration.
Over the period, EBITDA shifted from −$2.8 million to −$21.6 million, a change of −671.1%. The operating result developed less favorably than sales. At the operating-margin level, the figure shifted from −153.4% to −866.6%. Cost pressure reduced operating profitability.
The final result was −3 million dollars initially and −21.5 million dollars in the final year. Profitability deteriorated further over the five years.
Overall conclusion
The results contain several connected negative signals. The constructive conclusion rests on revenue expansion. Caution is warranted because of declining net profitability, weaker operating efficiency and a low EBITDA margin. Future reports should be judged by revenue momentum, margins, and the conversion of sales into net income.
Annual Income Statement GeoVax Labs
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.23 M | 266 K | 4.72 M | 758 K | 10.8 M | 6.47 M | 39.3 K | 4.16 M | 3.08 M | 2.54 M | 2.4 M | 5.73 T | 10.4 T | 12.8 T | 13.7 T | - | - | - | - | - | - | - | - | - | - |
Shares |
958 K | 207 K | 1.82 M | 1.13 M | 6.1 M | 1.38 M | 60.4 K | 160 | 70 | 40 | 30 | 26.6 M | 21.2 M | 18.3 M | 15.7 M | 15.7 M | 15.2 M | - | - | - | - | - | - | - | - |
Historical Prices |
1.28 | 1.28 | 2.6 | 0.67 | 1.77 | 5.1 | - | - | - | - | - | - | - | - | - | ||||||||||
Net Income |
-21.5 M | -25 M | -26 M | -14 M | -18.6 M | -2.96 M | -2.37 M | -2.56 M | -2.17 M | -3.27 M | -2.69 M | -2.73 M | -2.28 M | -2.14 M | -2.35 M | -2.75 M | -3.28 M | -3.73 M | -4.24 M | -584 K | -1.61 M | -2.35 M | -948 K | -618 K | -171 K |
Revenue |
2.49 M | 3.95 M | - | 81.5 K | 386 K | 1.82 M | 1.18 M | 963 K | 1.08 M | 829 K | 428 K | 883 K | 2.42 M | 2.66 M | 4.9 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | 883 K | 2.42 M | 2.66 M | 4.9 M | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-21.6 M | -25.1 M | -26.7 M | -14 M | -18.7 M | -2.82 M | -2.37 M | -2.56 M | -2.17 M | -3.27 M | -2.69 M | -2.74 M | -2.29 M | -2.14 M | -2.35 M | -2.77 M | -3.32 M | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | 1.29 K | 144 K | 4.5 K | 2.59 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-21.6 M | -25 M | -26.7 M | -14 M | -18.7 M | -2.8 M | -2.36 M | -2.54 M | -2.15 M | -3.24 M | -2.67 M | -2.67 M | -2.21 M | -2.05 M | -1.81 M | -2.65 M | -3.23 M | - | - | - | - | - | - | - | - |
Operating Expenses |
24.1 M | 29.1 M | 26.7 M | 14.1 M | 19.1 M | - | 3.55 M | 3.53 M | 3.25 M | 4.1 M | 3.12 M | 3.62 M | 4.71 M | 4.8 M | 7.25 M | 7.96 M | 6.98 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
6.01 M | 5.39 M | 6.02 M | 4.99 M | 3.58 M | 2.2 M | 1.64 M | 1.65 M | 1.23 M | 2.13 M | 1.43 M | 1.81 M | 1.79 M | 1.75 M | 2.97 M | 3.16 M | 2.91 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement GeoVax Labs
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.57 M | 2.01 M | 20.3 M | 15.4 M | 12 M | 10.5 M | 6.4 M | 2.54 M | 2.37 M | 1.98 M | 1.77 M | 1.56 M | 1.76 M | 26.3 M | 23.5 M | 12.7 M | 7.11 M | 6.38 M | 6.35 M | 6.32 M | 5.33 M | 3.83 M | 783 K | 691 K | 234 K | 15 K | 331 | 328 | 246 | 219 | 335 K | 310 K | 248 K | 107 M | 67 M | 59.8 M | 55.4 M | 55.2 M | 44.3 M | 37.4 M | 34.6 M | 32 M | 32 M | 32 M | 32 M | 32 M | 25.3 M | 25.1 M | 32 M | 23.8 M | 21.7 M | 21.1 M | 20.2 M | 18.7 M | 18.5 M | 17.8 M | 16.7 M | 16.4 M | 15.8 M | 15.7 M | 16.4 M |
Net Income |
-4.43 M | -5.26 M | -6.32 M | -5.37 M | -5.36 M | - | -5.82 M | -5.06 M | -5.85 M | - | -8.41 M | -5.93 M | -4.04 M | - | -3.97 M | -2.24 M | -2.43 M | - | -1.95 M | -1.31 M | -1.56 M | - | -571 K | -455 K | -596 K | - | -424 K | -654 K | -701 K | - | -667 K | -637 K | -622 K | - | -589 K | -517 K | -548 K | - | -464 K | -576 K | -1.3 M | -693 K | -620 K | -676 K | -700 K | -924 K | -515 K | -680 K | -700 K | -872 K | -190 K | -526 K | -697 K | -610 K | -297 K | -498 K | -731 K | -1.15 M | -376 K | -211 K | -606 K |
Revenue |
- | - | - | 852 K | 1.64 M | - | 2.79 M | 301 K | - | - | - | - | - | - | - | - | 81.5 K | - | 30.4 K | 79.7 K | 110 K | - | 415 K | 441 K | 716 K | - | 333 K | 210 K | 364 K | - | 349 K | 93.3 K | 221 K | - | 248 K | 352 K | 296 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4.44 M | -5.27 M | -6.37 M | -5.42 M | -5.41 M | - | -5.85 M | -5.06 M | -5.88 M | - | -8.6 M | -6.18 M | -4.27 M | - | -3.97 M | -2.24 M | -2.43 M | - | -1.95 M | -1.49 M | -1.56 M | - | -436 K | -448 K | -595 K | - | -426 K | -654 K | -702 K | - | -667 K | -638 K | -623 K | - | -590 K | -518 K | -549 K | - | -465 K | -576 K | -1.3 M | - | -621 K | -678 K | -702 K | - | -515 K | -681 K | -702 K | - | -191 K | -527 K | -698 K | - | -298 K | -499 K | -731 K | - | -376 K | -212 K | -607 K |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 531 | 755 | - | 134 K | 7.15 K | 1.14 K | - | 1.05 K | 1.09 K | 1.13 K | - | 625 | 625 | 208 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-4.42 M | -5.26 M | - | - | -5.39 M | - | - | - | -5.86 M | - | - | - | -4.25 M | - | -3.93 M | -2.24 M | -2.42 M | - | -1.92 M | -1.49 M | -1.56 M | - | -433 K | -441 K | -594 K | - | -420 K | -650 K | -700 K | - | -652 K | -628 K | -618 K | - | -570 K | -504 K | -542 K | - | -443 K | -562 K | -1.29 M | - | -600 K | -664 K | -694 K | - | -465 K | -648 K | -685 K | - | -139 K | -492 K | -680 K | - | -228 K | -452 K | -708 K | - | -295 K | -158 K | -580 K |
Operating Expenses |
4.44 M | 5.27 M | 6.37 M | 6.27 M | 7.04 M | - | 8.64 M | 5.36 M | 5.88 M | - | 8.6 M | 6.18 M | 4.27 M | - | 3.97 M | 2.24 M | 2.51 M | - | 1.98 M | 1.57 M | 1.67 M | - | 852 K | 889 K | 1.31 M | - | 759 K | 864 K | 1.07 M | - | 1.02 M | 731 K | 844 K | - | 838 K | 870 K | 844 K | - | 905 K | 742 K | 1.34 M | - | 714 K | 750 K | 805 K | - | 837 K | 861 K | 805 K | - | 1.2 M | 969 K | 1.49 M | - | 936 K | 1.2 M | 1.59 M | - | 1.67 M | 1.96 M | 1.5 M |
General and Administrative Expenses |
1.33 M | 1.37 M | 1.33 M | 1.54 M | 1.69 M | - | 1.24 M | 1.09 M | 1.46 M | - | 1.65 M | 1.46 M | 1.45 M | - | 1.25 M | 935 K | 1.18 M | - | 757 K | 733 K | 1.07 M | - | 435 K | 427 K | 502 K | - | 291 K | 413 K | 510 K | - | 459 K | 359 K | 357 K | - | 340 K | 352 K | 293 K | - | 221 K | 345 K | 907 K | - | 336 K | 365 K | 401 K | - | 412 K | 345 K | 401 K | - | 316 K | 19.6 K | 219 K | - | 334 K | 492 K | 513 K | - | 583 K | 579 K | 662 K |
All numbers in USD currency
The income statement is one of the three key financial reports of a company GeoVax Labs (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Canada
China
USA
France
Singapore
Britain
Germany
Israel
Russia
Belgium
Niderland
Irlanda
